These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Editorial: BCG in cancer. Br Med J; 1976 Jun; 1(6024):1487. PubMed ID: 776334 [No Abstract] [Full Text] [Related]
9. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy. Domenick NP Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752 [No Abstract] [Full Text] [Related]
10. Immunotherapy in malignant melanomaa. Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of cancer in man. Carter SK Am Sci; 1976; 64(4):418-23. PubMed ID: 786091 [No Abstract] [Full Text] [Related]
12. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [TBL] [Abstract][Full Text] [Related]
13. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer. Wile AG; Sparks FC; Morton DL Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610 [TBL] [Abstract][Full Text] [Related]
14. [Current status of immunotherapy of malignant tumors]. Flad HD; Betzler M; Herfarth C Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730 [No Abstract] [Full Text] [Related]